WASHINGTON (AP) — A new strategy to fight an extremely aggressive type of brain tumor showed promise in a pair of experiments with a handful of patients.
Scientists took patients’ own immune cells and turned them into “living drugs” able to recognize and attack glioblastoma. In the first-step tests, those cells shrank tumors at least temporarily, researchers reported Wednesday.
So-called CAR-T therapy already is used to fight blood-related cancers like leukemia but researchers have struggled to make it work for solid tumors. Now separate teams at Massachusetts General Hospital and the University of Pennsylvania are developing next-generation CAR-T versions designed to get past some of glioblastoma’s defenses.
“It’s very early days,” cautioned Penn’s Dr. Stephen Bagley, who led one of the studies. But “we’re optimistic that we’ve got something to build on here, a real foundation.”
Related articles:
Related suggestion:
Revealed: Ministers considered a RwandaWhere were Kanye West and Bianca Censori's Met Gala invites? As his exParis 2024 torch relay cauldron design unveiledChinese paddlers stunned at WTT 2024 Saudi SmashNew York City jail guard suffers burns from body camera ignitingMy top diet tricks to lower your blood pressure WITHOUT taking pillsWilson wins firstJudge: Alabama groups can sue over threat of prosecution for helping with abortion travelStar guard Kadary Richmond transfers to St. John's from Big East rival Seton HallI was left with second
3.1434s , 6502.25 kb
Copyright © 2024 Powered by New strategy to attack aggressive brain cancer shows promise ,Global Gazette news portal